Murat Bektaş

Number of international publications: 40 (indexed in PubMed)

Q1: 13 pieces

Q2: 5 pieces

Q3: 12 pieces

Q4/ESCI/Scopus/Other: 10 items

1. Name, author, number of international publications: 12

Last author’s number of international publications: 7

 

Number of national broadcasts: 4

1. Name, number of national publications: 2

1. Articles published in international peer-reviewed journals

1. NT-proCNP levels predict higher atherosclerotic cardiovascular risk profile in patients with proliferative diabetic retinopathy

Karaca C., Bektas M., Dincer M. Z., Bakkaloglu OK, Cebeci Z., Bakirkayia., Seyahin., Trabulus S., Tukek T. Acta Diabetologica, vol. 60, no. 8, pp. 1027-1036, 2023 (SCI/SCI-Expanded) (Q1)

2. Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the Pandemic.

AmikishiyevS.,GunverM.G., BektasM .,Aghamuradov S., InceB.,KocaN.,TorunE.S.,AliyevaN.,SariS.,CetinC.,et al. Arthritis & Rheumatology (Hoboken, NJ), vol.75, p.5, pp.664-672,2023) (SCI/SCI-Expanded) (Q1)

3. High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center

BEKTAŞM ., YÜCES.,Ay M.,UyarM.H.,OnderM.E.,KilicM. I. INFLAMMOPHARMACOLOGY, vol.31, p.2, pp.787-797,2023 (SCI/SCI-Expanded) (Q1)

4. A case of systemic lupus erythematosus presenting with intestinal lymphangiectasia-associated protein-losing enteropathy accompanied by hyperinflammation .

BektaşM .,Taş O.,OrduM. International Journal of Rheumatic Diseases, vol.26, p.3, pp.591-598,2023 (SCI/SCI-Expanded) (Q3)

5. Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with familial Mediterranean fever: a propensity score-matched cohort study.

MiriogluS., DirimA.B., BektasM ., DemirE., Tor .B., OzlukY., KilicaslanI., OtoÖ.A., YalcinkayaY., CaliskanY., et al. Nephrology, dialysis, transplantation: of the European and Transplant Association, European Renal Association ,2022 (SCI/SCI-Expanded) (Q1)

6. Performances of different classification criteria for systemic lupus erythematosus in a single-center cohort from Turkey, TORUNE.S., BEKTAŞE., KEMİKF., BEKTAŞM ., ÇETİNÇ., YALÇINKAYAY., EsenB.A., GÜLA., İNANÇM. LUPUS, vol.31, no.12, pp.1536-1543,2022 (SCI/SCI-Expanded) (Q3)
7. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and COVID-19: The Clinical Course and Prognosis of 15 Patients From a Tertiary Care Center . İnceB., BektaşM .,KocaN.,AğargünB.F.,ZaraliS.,GüzeyD.Y.,DurakG.,YalçinkayaY.,Artim-EsenB.,GülA.,etal. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, vol.28, p. 6, pp.300- 304,2022 (SCI/SCI-Expanded) (Q3)
8. Malnutrition treatment and follow-up in clinical nutrition outpatient clinics associated with increased muscle mass

SakaB., BektasM .,BakkalogluO.K.,Amikishiyev S.,SarıbeylilerG.,TiryakiT.O., InceB.,CakmakR.,Buyukdemir S., SenturkB.O.,etal. NUTRITION, vol.101,2022 (SCI/SCI-Expanded) (Q1)

9. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.

OztasM. BektasM . KaracanI., AliyevaN., DagA., Aghamuradov S., CevirgenS.B., SariS., BolayirliM., CanG., et al. Journal of Medical Virology , vol.94, pp.3431-3437,2022 (SCI/SCI-Expanded) (Q1)

10. Description of damage in different clusters of patients with antiphospholipid syndrome.

UludağÖ.,ÇeneE.,GurelE.,ÇetinÇ., BektaşM. ,YalçınkayaY.,Diz-KüçükkayaR.,GülA.,InançM.,Artim-EsenB. Lupus, vol.31, no.4, pp.433-442,2022 (SCI/SCI-Expanded) (Q3)

11. Protracted or recurrent COVID-19-associated cytokine storm in a patient with chronic lymphocytic leukemia receiving rituximab-based chemotherapy

Bektaş M., Özdemir G. Clinical Immunology , vol. 236, 2022 (SCI/SCI-Expanded) (Q1)

12. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

Mert A., Vahaboğlu H., Arslan F., Batirel A., Saracoğlu K. T., Bastuğ A., Cagatay A., Irmakı A., Tellidizman G., Ertenli I., Bektaş M., et al . RHEUMATOLOGY INTERNATIONAL, vol. 42, no. 3, pp. 457-467, 2022 (SCI/SCI-Expanded) (Q2)

13. Pure Red Cell Aplasia in IgG4-Related Disease: Successful Treatment With Cyclosporine.

BektaşM.AğargünB.F .,TorunE.S.,ÇatmaY.,BeşişikS.F.,NalçaciM.,YegenG.,YalçinkayaY.,EsenB.A.,GülA.,et al. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, vol.27,2021 (SCI/SCI-Expanded) (Q3)

14. A single-center survey study of systemic vasculitis and COVID-19 during the first months of the pandemic

InceB., BektaşM ., KocaN., AğargünB.F., ZaraliS., GüzeyD.Y., InceA., SevdiM.S., YalçinkayaY., ArtimEsenB., et al. Turkish Journal of Medical Sciences, vol. 51, no. 5, pp. 2243-2247, 2021 (SCI/SCI-Expanded) (Q3)

15. A shared motif of hla-dpb1 affecting the susceptibility to PR3-ANCA positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls

InceB.,KamaliS., BektasM .,OgretY.,SavranF.,YalcinkayaY.,Artim-EsenB., InancM.,OcalL.,GülA. RHEUMATOLOGY INTERNATIONAL, vol.41, no.9, pp.1667-1672, 2021 (SCI/SCI-Expanded) (Q3)

16 . Validation of the adjusted global antiphospholipid syndrome score in a single-center cohort of APS patients from Turkey.

UludağÖ., BektaşM .,CeneE.,SezerM.,SahinkayaY.,GülA., İnançM.,OcalL.,Artim-EsenB. Journal of Thrombosis and Thrombolysis, vol.51, p.2, pp.466-474,2021 (SCI/SCI-Expanded) (Q3)

16. Characteristics of Patients With Behçet Disease From the Van Province, Eastern Turkey: Definition of Disease Clusters in a Tertiary Referral Center

Oguz, Emin MD ^∗ ; Bektaş, Murat MD ^† JCR: Journal of Clinical Rheumatology   DOI:  10.1097/RHU.0000000000001996 (SCI-Expanded) (SCI/SCI-Expanded) (Q3)

17. Malnutrition risk in hospitalized patients measured with Nutrition Risk Screening 2002 tool and its association with in-hospital mortality. European Review for Medical and Pharmacological Sciences, July 2023 . 27(12):5812-582.

OK BAKKALOGLU1, M. BEKTAS , B. INCE, S. AMIKISHIYEV, YB TOR, M. ALTINKAYNAK, Y. GÖKSOY, B. ÖZMEN, S. BÜYÜKDEMİR, SN ERTEN,TS AKPINAR,B.SAKA
(SCI/SCI-Expanded) (Q2)

18. Prognostic and Predictive Value of Baseline Hypogammaglobulinemia for Chronic Lymphocytic Leukemia Prognosis and Complications.

Fatih Kus, Murat Bektas , Naci Senkal, Yunus Catma, Fatih Atalah, Arif Akyildiz, Sule Gumurdu, Meliha Nalcaci DOI: 10.14744/ejma.2023.20592 (Other international index)

19. Course and Prognosis of AA Amyloidosis in Patients with Psoriatic Arthritis: Report of Three Cases from a Single Center Cohort and Review of the Literature.

Bektaş M., Koca N., Ince B., Yalçınkaya Y., Esen B. A., Öcal M. L., Gül A., Inanç M. Mediterranean Journal of Rheumatology, vol. 33, no. 2, pp. 185-195, 2022 (Scopus)

20. PREDICTIVE RELEVANCE OF DIFFERENT CLINICAL AND LABORATORY FINDINGS FOR HIGHER MORTALITY IN PATIENTS WITH COVID-19 IN A SINGLE CENTER COHORT: NEUTROPHIL/LYMPHOCYTE RATIO, HIGH CRP, GGT, AND CREATININE LEVELS ARE ASSOCIATED WITH HIGH MORTALITY

EVLİCEO., Kuş F.,ARIK Ö., BEKTAŞM . JOURNAL OF ISTANBUL FACULTY OF MEDICINE, vol.85, pp.139-146, 2022 (ESCI)

21. EUTHYROID SICK SYNDROME: PREVALENCE AND PROGNOSIS IN ELDERLY PATIENTS WITH SEPSIS

CakmakR., AticiA., BEKTAŞM ., AKPINART.S., KÖSEM., YuruyenG., BakkalogluO.K., TokekT. JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIPFAKULTESIDERGISI, vol.85, pp.477-484, 2022 (ESCI)

22. A rare case of hydatid cyst-associated AA amyloidosis and literature review of hydatid cyst-associated nephropathy

D Seyhan Erdoğan, C Karaca, M Bektas , Z Akman İlik, M Erdem

Infectious Diseases, 1-7 (SCI/SCI-Expanded) (Q1)

23. Characteristics and course of patients with AA amyloidosis: single-center experience with 174 patients from Turkey

M Bektaş , N Koca, E Oguz, S Sari, G Dagci, B Ince, PK Ozer, BF Agargun, …

Rheumatology (Oxford). 2024 Feb 1;63(2):319-328. doi: 10.1093/rheumatology/kead465.PMID:  37738242 (SCI/SCI-Expanded) (Q1)

24. Utility of Positron Emission Tomography as a New Tool for Muscle Involvement in Patients with Idiopathic Inflammatory Myositis: A Controlled Study
    M. Bektaş , EG Işık, E. Oğuz, F. Kemik, A. Abbasgholizadeh, B. İnce, ZG Özkan, Y. Yalçınkaya, BA Esen, A. Gül, M. İnanç. Clin Exp Rheumatol. 2024 Feb;42(2):358-366. doi: 10.55563/clinexprheumatol/9u122p. Epub 2024 Jan 29. PMID: 38293968  (SCI/SCI-Expanded) (Q3)
25. Intravenous High-dose Anakinra Drops Venous Thrombosis and Myocardial Infarction in Severe and Critical COVID-19 Patients: A Propensity Score Matched Study

R Çakmak, S Yüce, M Ay, MH Uyar, M Bektas

Sci Rep. 2024 May 29;14(1):12369. doi: 10.1038/s41598-024-62079-y.PMID: 38811592 (SCI/SCI-Expanded) (Q1)

27. Combination Therapy of High-dose Intravenous Anakinra and Baricitinib in Patients with Critical COVID-19: Promising Results from Retrospective Observational Study

Bektaş M , Ay M, Hamdi Uyar M, İkbal Kılıç M. Int Immunopharmacol. 2024 Mar 10;129:111586. doi: 10.1016/j.intimp.2024.111586. Epub 2024 Feb 3. PMID: 38309091

(SCI/SCI-Expanded) (Q1)

28. Safety and Efficacy of TNF Inhibitors in Patients with Behçet’s Disease: Retrospective Study from Eastern Turkey

Murat Bektaş , MD, Emin Oğuz, MD, Muhammet Derda Özer

Clin Immunol. 2024 Jul;264:110239. doi: 10.1016/j.clim.2024.110239. Epub 2024 May 9.PMID: 38734038 (SCI/SCI-Expanded) (Q1)

29. Validation of Turkish Psoriatic Arthritis Screening Tool (TurPAS) for Psoriatic Arthritis: A Cross-sectional Comparative Study

Şeyma Başar Kılıç MD ¹ , Huzeyfe Kulu MD ¹ , Hüseyin Salman MD ¹ , Murat Bektaş MD

Medicine (Baltimore). 2025 Aug 29;104(35):e44013. doi: 10.1097/MD.0000000000044013.PMID: 40898568 (SCI/SCI-Expanded) (Q2)

30. Association of serum KL-6 levels and disease severity in patients hospitalized with COVID-19

Evlice O,  Bektaş M , Kar F, Marim F, Kaya İ, Yörükoğlu K, Ak Ö.

Infect Dis Clin Microbiol. 2023 Dec 29;5(4):292-299. doi: 10.36519/idcm. 2023,260. eCollection 2023 Dec.PMID: 38633849 (ESCI)

31. Evaluation of therapeutic plasma exchange in anti-neutrophil cytoplasmic antibody-associated vasculitis in real-life settings: long-term results of propensity score matching analysis in high-risk patients BI·nce, M Bektaş ¸, ÜA Gülseren, E Ük, B Çelik, S Yüce, S Dadin, H Yazici, Y Yalçinkaya, B Artim-Esen, A Gül, S Kalayoglu-Bes¸is¸ik & MI·faith. Scandinavian Journal of Rheumatology (SCI/SCI-Expanded) (Q3)
32. Minimal disease activity and associated factors in patients with psoriatic arthritis: cross-sectional study from a single center

M Bektas , B Çelik, B İnce, Y Yalçınkaya, BA Esen, A Gül, M İnanç

Reumatologia 62 (5), 330. (ESCI-SCOPUS/PUBMED)

33. Damage accrual and predictors of mortality in ANCA-associated vasculitis: a retrospective observational study

Murat Bektaş ^{1 , 4} , Burak Ince ¹ , Sibel Zaralı ² , Übeyde Ayşe Gülseren ² , Ece Ük ² , Besim Fazıl Ağargün ² , Damla Yenersu Güzey ³ , Yasemin Yalçınkaya ¹ , Bahar Artım-Esen ¹ , Ahmet Gul ¹ , Murat İnanç

Rheumatol Int. 2025 May 7;45(5):137. doi: 10.1007/s00296-025-05883-7.PMID: 40332571 (SCI/SCI-Expanded) (Q2)

34. Transient Elastography Measurements of the Liver and Transplanted Kidney in Patients with AA Amyloidosis: A Cross-sectional Comparative Study

Murat Bektas ^1,8 , Bilger Cavus ² , Besim Fazil Agargün ³ , Ibrahim Volkan Senkal ² , Nevzat Koca ¹ , Burak Ince ¹ , Selma Sari ¹ , Ahmet Burak Dirim ⁴ , Metban Güzel Mastanzade ⁵ , Gizem Dagci ³ , Pelin Karaca Ozer ⁶ , Mehmet Aydogan ⁶ , Melek Büyük ⁷ , Yasemin Yalcinkaya ¹ , Bahar Artim-Esen ¹ , Murat Inanc ¹ , Mine Güllüoglu ⁷ , Halil Yazici ⁴ , Sevgi Kalayoglu Besisik ⁵ , Selman Fatih Besisik ² , Ahmet Gul ¹ * Rheumatol Int. 2025 Jul 1;45(7):162. doi: 10.1007/s00296-025-05906-3.PMID: 40593362

(SCI/SCI-Expanded) (Q2)

35. Presence of Myositis Specific Autoantibodies Predicts Favorable Outcomes to Rituximab in Patients with Idiopathic Inflammatory Myositis: Retrospective Observational Study

Oguz E, Koca N,  Bektas M . Mod Rheumatol. 2026 Apr 13;36(3):407-414. doi: 10.1093/mr/roaf097.PMID: 41065672 (SCI/SCI-Expanded) (Q3)

36. Potential Predictors of the Outcome of Tocilizumab Treatment in Patients with COVID-19-Associated Hyperinflammation

Shirkhan Amikishiyev ^1 2 ,  Murat Bektaş ¹ ,  Mehmet Güven Günver ³ , Burak İnce ¹ , Sarvan Aghamuradov ¹ , Nevzat Koca ¹ , Naci Şenkal ⁴ , Görkem Durak ⁵ , Murat Köse ⁴ , Mustafa Erelel ⁶ , Arif Atahan Çağatay ⁷ , Serap Şimşek-Yavuz ⁷ , Sevgi Kalayoğlu-Beşışık ⁸ , Figen Esen ⁹ , Ahmet Gül ¹                

Infect Dis Clin Microbiol. 2025 Jun 26;7(2):185-194. doi: 10.36519/idcm. 2025.475.

eCollection 2025 Jun.PMID: 40657013  (Ulakbim/ESCI).

37. Antibiotic Use among Patients Hospitalized with COVID-19 and Treated in Three Different Clinics

EvliceO., ŞenerA., ÖzatağD.M., AkÖ., BektaşM .,ArıkÖ.,AcetA., MarimF.,Kaya İ. Infectious Diseases and Clinical Microbiology (Online), vol.4, no.3, pp.199-205,2022 (Ulakbim/ESCI).

38. 38 . Persistent Symptoms After Discharge of COVID-19 patients

EvliceO., Kuş F. , Bektas M. Infectious disease and clinical microbiology, vol.3, sa.1, pp.22-30,2021 (Ulakbim/ESCI)

39. 39 . Individualized High-Dose Intravenous Anakinra Treatment in Cancer Patients with COVID-19 Associated Cytokine Storm: A Retrospective Controlled Study.

Çakmak R,  Bektaş M.

Infect Dis Clin Microbiol. 2024 Mar 8;6(1):32-43. doi: 10.36519/idcm. 2024,287. eCollection 2024 Mar.PMID: 38633444 (Ulakbim/ESCI)

40. 40 . Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra.

Amikishiyev S, Deniz R, Gunver MG, Aghamuradov S, Koca N, Ince B,  Bektas M , Yilmaz A, Canturk Y, Durak G, Kose M, Erelel M, Çağatay AA, Yavuz SS, Kalayoglu Besisik S, Esen F, Gül A.

Front Immunol. 2026 May 22; 17:1722572. doi: 10.3389/fimmu. 2026.1722572. eCollection 2026.PMID: 42253999  (SCI/SCI-Expanded) (Q1)

Papers presented at international scientific meetings and published in the proceedings .

1. A NEWSCREENING TOOL FOR PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS: TURPAS AYANG. ,HatemiG.,CanG., BektasM .,OzdedeA.,AkdoganN.,Yalici-ArmaganB.,SolakE.O.,YaziciS.,AdisenE.O.,et al. ANNALSOF THERHEUMATICDISEASES, vol.81, pp.1597-1598,2022 (SCI-Expanded)0

2. DEVELOPMENT OF MALIGNANCY IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS BEKTAŞM ., İNCEB., ZARALI S., GÜLSERENÜ.A., ÜKE., AĞARGÜNB.F., GuzeyD.Y., YALÇINKAYAY., Artim-EsenB., GÜLA., et al. ANNALSOF THERHEUMATICDISEASES, pp.1430-1431, 2022 (SCI-Expanded)

3. DIFFERENCES IN THE CLINICAL SPECRUMOF HAPLOINSUFFICIENCY OF A20 (HA20) CASES DIAGNOSED DURING ADULTHOOD Amikishiyev S.,AliyevaN., BektasM .,KocaN.,Soltanova L.,YalcinkayaY.,Artim-EsenB., InancM.,GulA. ANNALSOF THERHEUMATICDISEASES, vol.81, pp.1756,2022 (SCI-Expanded)

4. TRANSIENT ELASTOGRAPHY (FIBROSCAN); AS A NEWNON-INVASIVE DIAGNOSTICMETHOD FOR DETECTING HEPATIC INVOLVEMENT OF AMYLOIDOSIS BEKTAŞM ., ÇAVUŞB.,AĞARGÜNB.F.,SenkalV.,KOCAN., İNCEB.,KARACAÖZERP.,MASTANZADEM.,BÜYÜKM., BUĞRAM.Z.,etal. ANNALSOF THERHEUMATICDISEASES, ss.1019,2022 (SCI-Expanded)

5. AMYLOID BURDEN AND ASSOCIATED FACTORS PREDICT HIGHERMORTALITY AND POOR OUTCOME IN FAMILIAL MEDITERRANEAN FEVER-ASSOCIATED AA AMYLOIDOSIS: DATA FROMA TERTIARY REFERRAL AMYLOIDOSIS CENTERWITH 137 PATIENTS BEKTAŞM . ,KOCAN.,OĞUZ E., İNCEB.,SARI S.,ŞENTÜRKN.,YALÇINKAYAY.,Artim-EsenB., İNANÇM.,GÜLA. ANNALSOF THERHEUMATICDISEASES, pp.348,2022 (SCI-Expanded)

6. PREDICTORS OF MORTALITY IN SEVERE AND CRITICAL COVID-19 PATIENTSWHO RECEIVED ANAKINRA BEKTAŞM . ,KilicM. I. ANNALSOF THERHEUMATICDISEASES, ss.948,2022 (SCI-Expanded)

7. FAVOURABLE SHORT-TERMCOURSE OF COVID-19 IN PATIENTSWITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS AliyevaN.,DulunduB.CY,Amikishiyev S.,Aghamuradov S., BEKTAŞM ., InceB.,KocaN.,YalcinkayaY.,Artim-Esen B., InancM.,etal. ANNALSOF THERHEUMATICDISEASES, vol.80, pp.913-914,2021 (SCI-Expanded)

8. MORE FREQUENT AND EARLIER HIP INVOLVEMENT IN SPONDYLOARTHRITIS ASSOCIATEDWITH FAMILIAL MEDITERRANEAN FEVER BEKTAŞM., SARI S. ,ÇETİNÇ. ,DulunduB.CY,KOCAN., İNCEB.,YALÇINKAYAY.,Artim-EsenB., İNANÇM.,ÖCALM., etal. ANNALSOF THERHEUMATICDISEASES, vol.80, pp.951-952,2021 (SCI-Expanded)

9. PERFORMANCES OF DIFFERENT CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN A SINGLE CENTER COHORT FROMTURKEY TORUNE.S., BEKTAŞE.,KEMİKF. , BEKTAŞM .,ÇETİNÇ.,YALÇINKAYAY.,Artim-EsenB.,GÜLA., İNANÇM. ANNALSOF THERHEUMATICDISEASES, vol.80, pp.602-603,2021 (SCI-Expanded)

10. HYPOGAMMAGLOBULINEMIA IS A SIGNIFICANT RISK FACTOR FORMORTALITY IN PATIENTSWITH ANCA ASSOCIATED VASCULITIS AND COVID-19 İNCEB., BEKTAŞM . ,KOCAN.,AĞARGÜNB.F.,ZARALI S.,GuzeyD.Y.,YALÇINKAYAY.,Artim-EsenB.,GÜLA., İNANÇ M. ANNALSOF THERHEUMATICDISEASES, vol.80, pp.912-913,2021 (SCI-Expanded)

11. DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTER COHORT OF 240 PATIENTSWITH ANTIPHOSPHOLIPID SYNDROME ARTIM-ESENB., SahinkayaY. ,YUCET., PEHLIVANO., BektasM .,TOZB.,ErerB.,KAMALI S.,GULA.,OCAL L.,etal. AnnualEuropeanCongress of Rheumatology (EULAR),London,Canada,8 -11June2016, vol.75, pp.1055
12. FEATURES AND RISK FACTORS OF SERIOUS INFECTIONS IN ANCA ASSOCIATED VASCULITIS: LONG TERMFOLLOWUP OF 186 PATIENTS InceB., BEKTAŞM .,KEMİKF.,AytunA.E.,YALÇINKAYAY.,Artim-EsenB.,GÜLA.,ÖCALM., İNANÇM. AnnualEuropeanCongress of Rheumatology (EULAR),ELECTRNETWORK,03June2020, vol.79, pp.1069

13. VALIDATION OF THE ADJUSTED GLOBAL ANTIPHOSPHOLIPID SYNDROME SCORE AND CORRELATION WITH EXTRA-CRITERIAMANIFESTATIONS UludagO. , BEKTAŞ M. , ÇENEE.,YalcinkayaY.,GulA., InancM.,OcalM.L.,Artim-EsenB. AnnualEuropeanCongress of Rheumatology (EULAR),ELECTRNETWORK,03June2020, vol.79, pp.1058

14. ANCA-ASSOCIATED VASCULITIS: CLINICAL FEATURES, RELAPSE, ORGAN DAMAGE AND SURVIVAL IN 197 PATIENTS BEKTAŞM. , InceB.,AgargunB.F.,GuzeyD.Y.,YalcinkayaY.,Artim-EsenB.,GulA.,OcalM.L., InancM. AnnualEuropeanCongress of Rheumatology (EULAR),ELECTRNETWORK,03June2020, vol.79, pp.1525

15. Efficacy and Safety of Interleukin-1 Blockers in Kidney Transplant Recipients with Familial Mediterranean Fever. Mirioğlu Ş., Dirim A.B., Bektaş M., Demir E., Tor YB, Yalçınkaya Y., Çalışkan Y.K., Artım Esen B., Yazıcı H., İnanç M., et al. 17th BANTAO Congress, Antalya, Turkey, 10 November 2022

16. FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTSWITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE OztasM., BEKTAŞM .,KaracanI.,AliyevaN.,DagA.,Aghamuradov S.,CevirgenS.B.,SariS.,BOLAYIRLI İ.M.,CANG., etal. EULAREuropeanCongress of Rheumatology (EULAR),Copenhagen,Denmark,1 -04June2022, vol.81, pp.1660-1661

17. AA AMYLOIDOSIS IN A PATIENTWITHMUTATIONS IN BOTH ADA2 AND A20 GENES Amikishiyev S., InceB., Bektas M. ,YalcinkayaY.,Artim-EsenB., InancM.,GulA. EULAREuropeanCongress of Rheumatology (EULAR),Copenhagen,Denmark,1 -04June2022, vol.81, pp.1756-1757

18. Is It Useful to AssessMuscle Involvementwith Positron Emission Tomography in Patients with Idiopathic InflammatoryMyositis? A Case-Control Study BektaşM. , IşıkE.G.,KemikF.,OğuzE.,AbbasgholıZadehA., İnceB.,ÖzkanZ.G.,YalçınkayaY.,ArtımEsenB.,GülA., etal. Americancollege of Rheumatology2021,Arizona,United States of America,5 -09November2021, vol.10, p.73, pp.1-5

19. Potential Predictors of Outcome for Anakinra Treatment in COVID-19 Patients with Macrophage Activation Syndrome. Amikishiyev S., Deniz R., Günver M. G., Aghamuradov S., Koca N., İnce B., Bektaş M., Durak G., Köse M., Erelel M., et al. American College of Rheumatology, Arizona, United States, 5-9 November 2021, vol. 10, no. 73, pp. 1-5.

20. Performances of Different Classification Criteria for Systemic Lupus Erythematosus in a Single Center Cohort from Turkey. Torun E.S., Bektaş E., Kemik F., Bektaş M., Çetin Ç ., Yalçınkaya Y., Artım Esen B., Gül A., İnanç M. American College of Rheumatology 2021, Arizona, United States, November 5-9, 2021, Vol. 10, No. 72, pp. 1-2.

21. Successful Treatment of Ankylosing Spondylitis Associated A.A. Amyloidosis with Secukinum A.B.: A Case Series with Three Patients. Bektaş M., Kocan E., Oğuz E., Çetinç E., İnce B., Yalçınkaya Y., Artim-Esen B., Öcal M., İnanç M., Güla. Annual European Congress of Rheumatology (EULAR), Electronic Network, June 2-5, 2021, Vol. 80, pp. 1409-1410

22. INSTRUMENTS FOR SCREENING PSORIATIC ARTHRITIS AMONG PATIENTS WITH PSORIASIS: A SYSTEMATIC LITERATURE REVIEW CANG.,AYANG.,OzdedeA., BEKTAŞM .,AKDOĞANN.,Yalici-ArmaganB.,ÖKSÜMSOLAKE.,YAZİCİ S.,KALYONCUU., ADIŞENE., et al. Annual European Congress of Rheumatology (EULAR), ELECTRNETWORK, 2-05 June 2021, vol.80, pp.1327

23. MINIMAL DISEASE ACTIVITY IN PATIENTSWITH PSORIATIC ARTHRITIS AND ASSOCIATED FACTORS: REAL LIFE DATA FROMA SINGLE CENTER BEKTAŞM .,ÇELİKB., İNCEB.,YALÇINKAYAY.,Artim-EsenB.,GÜLA.,ÖCALM., İNANÇM. EuropeanCongress of Rheumatology,ELECTRNETWORK,01January2021, vol.80, pp.282-283

24. CLINICAL ASPECTS, LABORATORY CHARACTERISTICS AND TREATMENT RESPONSES OF AA AMYLOIDOSIS: SINGLE CENTER EXPERIENCEWITH 163 PATIENTS BEKTAŞM .,KocaN.,OguzE., InceB.,YalcinkayaY.,Artim-EsenB., InancM.,OcalM.L.,GulA. AnnualEuropeanCongress of Rheumatology (EULAR),ELECTRNETWORK,03June2020, vol.79, pp.171 XXXV. VALIDATION OF THE ADJUSTED GLOBAL ANTIPHOSPHOLIPID SYNDROME SCORE AND CORREL

25. TNF INHIBITORS ARE SAFE AND EFFECTIVE IN PATIENTS WITH SEVERE BEHÇET’S DISEASE: DATA FROM EASTERN TURKEY, INTERSECTION OF THE SILK ROAD

M Bektaş, E Oguz, M Özer. Annals of the Rheumatic Diseases 82 (Suppl 1), 1980-1980

26. HIGHER VASCULAR INVOLVEMENT IN BEHÇET’S DISEASE AMONG KURDISH ETHNICITY: DATA FROM A SINGLE CENTER AT INTERSECTION OF SILK ROAD IN EASTERN TURKEY

E Oguz, M Bektaş , Annals of the Rheumatic Diseases 82 (Suppl 1), 1986-1987

27. AB0791 EVALUATION OF THE EFFICACY AND COMPLICATIONS OF PLASMA EXCHANGE IN ANCA-ASSOCIATED VASCULITIS: RESULTS OF PROPENSITY SCORE MATCHING ANALYSIS IN HIGH-RISK PATIENTS

B Ince, M Bektas , B Celik, S Yüce, Y Yalçinkaya, B Artim-Esen, A Gül, …Annals of the Rheumatic Diseases 82 (Suppl 1), 1607-1607

28. HIGH DOSE INTRAVENOUS ANAKINRA TREATMENT IS SAFE AND EFFECTIVE IN SEVERE AND CRITICAL COVID-19 PATIENTS: A PROPENSITY SCORE MATCHED STUDY IN A SINGLE CENTER

M Bektaş , S Yüce, M Ay, M Uyar, M Önder, Mİ Kiliç, Annals of the Rheumatic Diseases 82 (Suppl 1), 544-544

1. National/international books or chapters in books that have been written

      C1. National/international books written

      C2. Chapters in national/international books

1. M Bektaş, B Artım Esen, Bes C, editors. Systemic Lupus Erythematosus 1, Türkiye Klinikleri, 105-12
2. AG Shirkhan AMIKISHİYEV, Murat Bektaş, Türkiye Klinikleri, 51-57
3. Guideline Recommendations for Patients with ANCA-Related Vasculitis. Murat Bektaş. Akademisyen Publishing House. 2023.

 

Articles published in national peer-reviewed journals

1. Experience with secukinumab in ankylosing spondylitis and psoriatic arthritis: Analysis of 44 patients from a single center.

BEKTAŞ M., ÇETİNÇ., YALÇINKAY., ESENB. A., ÖCAL L., GÜLA., İNANÇ M., UĞURLUÇ. B., ÇİFTÇİ A. C. National Journal of Rheumatology, Vol. 13, No. 3, pp. 116-120, 2021 (Ulakbim)

2. Investigation of methicillin-resistant Staphylococcus aureus colonization on stethoscopes. Fışkırma İ.A., Bektaş M., Kimyon U., Ergin Ç. Pamukkale Medical Journal, vol. 3, no. 3, pp. 116-118, 2011 (Ulakbim)

3. Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High-Dose Intravenous Anakinra Year 2023, Volume: 8 Issue: 1, 7 – 16, 29.03.2023.

Murat BEKTAŞ   Muhammed İkbal KILIÇ. (Ulakbim) / /doi.org/10.58854/jicm.1247409

4. Evaluation and comparison of ACR/EULAR 2022 ANCA-related vasculitis classification criteria with existing criteria.

B İnce, N Koca, M Bektaş , D Altunok, Y Yalçınkaya, A Gül, ML Öçal, …

Journal of Turkish Society for Rheumatology. ( Ulakbim)

Papers presented at national scientific meetings and published in proceedings books.

1. Investigation of findings that can predict the response to anakinra treatment in patients with COVID-19-related macrophage activation syndrome. Amikishiyev S., Deniz R., Günver M.G., Aghamuradov S., Koca N., İnce B., Bektaş M., Yılmaz A., Cantürk Y., Durak G., et al. RheumatologyTarget2021, Istanbul, Turkey, 27 October-30 November 2021, pp. 10-11.
2. Frequency and course of COVID-19 infection in patients with systemic sclerosis: A one-center experience. Aliyeva N., Yalçınkaya Y., Amikshiyev S., Bektaş M., Demir B., Can M.G., Cömert R.G., Artım Esen B., Gül A., İnanç M. Rheumatology Target 2021, Istanbul, Turkey, 27-30 October 2021, pp. 12-13. VI I. Frequency and course of COVID-19 infection in patients with systemic sclerosis: A one-center experience.
3. Transient elastography (fibroscan) as a non-invasive method for detecting AA amyloidosis recurrence in renal transplant recipients. Bektaş M., Dirim A.B., Çavuş B., Sarı S., Şenkal İ.V., Ağargün B.F., Koca N., İnce B., Yalçınkaya Y., Artım Esen B., et al. Rheumatology Target 2021, Istanbul, Turkey, 27-30 October 2021, pp. 1-2
4. Performance of parameters used in psoriatic arthritis screening tools in patients with psoriasis: A systematic literature review. AyanG., CanG., BektaşM ., ÖzdedeA., AkdoğanN., YalıcıArmağanB., ÖksümSolakE., YazıcıS., HatemiG., AdışenE., et al. National Rheumatology 2021, Antalya, Turkey, 29 September – 03 October 2021, vol.1, pp.32-33
5. Experience with Secukinumab in a Case of Ankylosing Spondylitis-Related Amyloidosis with Demyelinating Polyneuropathy Developing After Infliximab . Bektaş M., Koca N., Oğuz E., İnce B., Yalçınkaya Y., Artım Esen B., Gül A., Öcal M. L., İnanç M. ANKARA RHEUMATOLOGY DAYS 2020, 4-6 September 2020, vol. 1, pp. 47
6. Risk factors associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus. ÇetinÇ.,Saraç SivrikozT.,AteşTıkızM., BektaşM .,ErsoyA.,YalçınkayaY.,GülA.,ÖçalM.L., İnançM.,ArtımEsenB. National Rheumatology Congress, Antalya, Turkey, 16-20 October 2019, pp.203-204
7. The Relationship Between Elevated Transaminase Levels and Clinical Response in Patients Diagnosed with Familial Mediterranean Fever. ŞentürkÖztaşN.,DenizR.,OğuzE.,ÇetinÇ., BektaşM .,ArtımEsenB., İnançM.,ÖçalM.L.,AralO.,GülA. National Rheumatology Congress, Antalya, Turkey, 16-20 October 2019, pp.69-70.
8. Clinical characteristics, survival, mortality and damage data of 197 ANCA-related vasculitis patients followed from a single center. BEKTAŞM ., İnceB.,AğargünB.F.,YALÇINKAYA(Şahinkaya) Y.,GüzeyD.Y.,ARTIMESENB.,GÜLA.,ÖÇALM.L., İNANÇM. XX.National Rheumatology Congress, Antalya, Turkey, 16-20 October 2019, pp.221-222 LVI.
9. Long-term development of serious infections and risk factors in ANCA-related vasculitis patients . Bektaş M. , İnce B., YALÇINKAYA (ŞAHİNKAYA) Y., Altun A. E., ARTIMESENB., GÜLA., ÖÇAL M. L., İNANÇ M. XX. National Rheumatology Congress, Antalya, Turkey, 16-20 October 2019, pp. 129-130 LVI I.
10. Adult Still’s Disease: Clinical findings, laboratory characteristics and biological agent use of 150 patients. Oğuz E., Tekin Uzman R.D., Dağcı G., Erdugan M., Bektaş M., Aghamuradov S., Artım Esen B., İnanç M., Öçal M.L., Gül A. National Rheumatology Congress, Antalya, Turkey, 26-30 September 2018, pp. 34-35
11. Avascular necrosis in patients with systemic lupus erythematosus: Prevalence, associations, risk factors and course. ÇetinÇ.,GöktaşAydınS.,ÇeneE.,ErsoyA.,Kapar C., BektaşM .,Aghamuradov S.,ÖçalM.L.,GülA., İnançM., et al. National Rheumatology Congress, Muğla, Turkey, 26-30 September 2018, pp.110-111
12. Clinical characteristics, biological treatment use and maintenance rates of 253 psoriatic arthritis patients followed from a single center . Bektaş M. , Oğuz E., Erdugan M., Çetin Ç., Aghamuradov S., Çapar G., Artım Esen B., Gül A., Öçal M. L., İnanç M. 19th National Rheumatology Congress, Muğla, Turkey, 26-30 September 2018, pp. 97-98.
13. COVID-19-Related Recurrent Macrophage Activation Syndrome Developing in a Chronic Lymphocytic Leukemia Patient Receiving Rituximab-Containing Chemotherapy. Bektaş M., Özdemir G. Rheumatology Update 2021, Adana, Turkey, 10-12 December 2021, pp. 40-420.

14. A case of systemic lupus erythematosus presenting with autoimmune hemolytic anemia associated with Kaposi’s sarcoma . Bektaş M. , Yağcı M.A., Artım Esen B., Gül A., İnanç M., Öçal M.L. Rheumatology Target 2018 Symposium, Istanbul, Turkey, 7-10 March 2018, pp. 54.

15. IgG4-related disease: A case of aortitis/periaortitis and acalculous cholecystitis. Oğuz E., Abbasgholı Zadeh A. , Bektaş M., Çetin Ç., Artım Esen B., Gül A., Öçal M.L., İnanç M. Rheumatology Target 2018 Symposium, Antalya, Turkey, 7-10 March 2018, pp. 47-48.

16. A Rare Clinical Finding of Dermatomyositis/Antisynthetase Syndrome: Palmoplantar Keratoderma. DağcıG.,OğuzE.,ErenN.,TekinUzmanR.D. , BektaşM .,ArtımEsenB.,GülA.,ÖçalM.L., İnançM. Rheumatology Target 2018 Symposium, Antalya, Turkey, 7-10 March 2018, pp.45-47

17. A case of lymphomatoid granulomatosis presenting as granulomatous polyangiitis with central nervous system involvement . Bektaş M. , Eren N., Oğuz E., Erdugan M., Çetin Ç., Aghamuradov S., Çapar G., Artım Esen B., Gül A., İnanç M., et al. National Rheumatology Congress, Muğla, Turkey, 26-30 September 2018, pp. 214.
18. A case of alpha-1 antitrypsin deficiency presenting with necrotizing panniculitis and asymmetric oligoarthritis. ÇetinÇ.,Kapar C.,ErsoyA., BektaşM .,BaykalC.,ÖçalM.L., İnançM.,GülA.,UygunerZO,ArtımEsenB. National Rheumatology Congress, Muğla, Turkey, 26-30 September 2018, pp.159-160.
19. A Rare Presentation of Systemic Lupus Erythematosus: Thrombotic Thrombocytopenic Purpura. Eren N., Aksoy E., Bektaş M., Oğuz E., Erdugan M., Çetin Ç., Aghamuradov S., Artım Esen B., Gül A., İnanç M., et al. National Rheumatology Congress, Muğla, Turkey, 26-30 September 2018, pp. 199-200.
20. A case of relapsing polychondritis presenting with chordal rupture. BektaşM .,Aghamuradov S.,YalçınkayaY.,ArtımEsenB.,GülA., İnançM.,ÖçalM.L. Target in Rheumatology2019 Symposium, Istanbul, Türkiye, 17 -20 April 2019, pp.86
21. A case of familial Mediterranean fever presenting with recurrent fever in the course of Goodpasture disease. Amikishiyev S., Bektaş M., Yalçınkaya Y., Artım Esen B., Yazıcı H., İnanç M., Öçal M. L., Gül A. Rheumatology Target 2019 Symposium, Istanbul, Turkey, 17-20 April 2019, pp. 76.
22. Clinical characteristics of patients diagnosed with amyloidosis-related goiter. Torun E.S., Mirioğlu Ş., Bektaş M., Canbay Torun B., Bakkaloğlu H., Türkmen A., Gül N., Yegen G., Gül A. 20th National Rheumatology Congress, Antalya, Turkey, 16-20 October 2019, vol. 11, pp. 54-55.
23. Experience with secukinumab in ankylosing spondylitis (AS) and psoriatic arthritis (PSA): Analysis of 45 patients from a single center . BEKTAŞM ., ÇETİNÇ., UğurluÇ., KemikF., YALÇINKAYAY., ARTIMESENB., GÜLA., ÖÇALM.L., İNANÇM. National Rheumatology Congress, Antalya, Turkey, 16-20 October 2019, pp. 242-243.
24. Systemic lupus erythematosus with widespread organ involvement and developing paradoxical emboli. Ağargün B.F., Koca N., Bektaş M., Kemik F., Yalçınkaya Y., Artım Esen B., Gül A., Öçal M.L., İnanç M. National Rheumatology Congress, Antalya, Turkey, 16-20 October 2019, pp. 205-206
25. Anticytokine Treatment Responses in Dementia Patients Followed Due to Severe and Critical COVID-19: A Retrospective Controlled Study. Bektaş M. , Kılıç M. İ. Traditional Internal Medicine Days 2022, Sakarya, Turkey, 24-27 March 2022, pp. 32-33.
26. Frequency of AA amyloidosis in psoriatic arthritis: A single-center experience. Murat Bektaş, Mahdume Lale Öçal, Yasemin Yalçınkaya, Bahar Artım Esen, Ahmet Gül, Murat İnanç, Nevzat Koca. Target Symposium in Rheumatology.
27. In patients with atrial amyloidosis, amyloid storm is associated with increased amyloid burden and high mortality. M Bektaş , S Sarı, N Koca, E Oğuz, B İnce, Y Yalçınkaya, BA Esen, M İnanç, …

Journal of Turkish Society for Rheumatology 14

 

28. Amyloid prevalence and related factors predict poor prognosis and high mortality in familial Mediterranean fever-related amyloidosis: Data from 137 patients.

M Bektaş, N Koca, E Oğuz, B İnce, S Sarı, N Şentürk, Y Yalçınkaya, …

Journal of Turkish Society for Rheumatology 14

29. Results of genetic investigations using a fever panel in patients suspected of having hereditary periodic fever syndrome.

S Amikishiyev, T Kalaycı, M Bektaş , Ç Çetin, S Aghamuradov, …

Journal of Turkish Society for Rheumatology 14

Art and design events

1. Rheumatology Update Meeting, December 10-12, 2021, Adana
2. National Rheumatology Congress, September 29-October 3, 2021, Antalya
3. TIHUD ASSIST CAMP, April 28-30, 2017, Bodrum
4. National Rheumatology Congress, October 18-22, 2017, Antalya
5. Traditional Internal Medicine Days, March 16-19, 2017, Sapanca
6. Mediterranean Congress of Rheumatology, August 18-31, 2014, Istanbul
7. Traditional Internal Medicine Days, March 11-13, 2016, Sapanca
8. Endocrinology and Metabolic Diseases Postgraduate Education Course and 13th Diabetes Days Symposium, November 14, 2015, Istanbul
9. National Internal Medicine Congress, October 14-18, 2015, Antalya
10. National Rheumatology Congress, October 29-November 2, 2014, Antalya
11. Çapa Nephrology Days, April 28-May 1, 2016, Sapanca
12. Çapa Gastroenterology Days, March 31-April 2, 2016, Istanbul
13. Koç University Pregnancy and Thyroid Symposium, December 12, 2015, Istanbul
14. National Hepatology Congress, May 17-21, 2017, Antalya
15. National Rheumatology Congress, October 16-20, 2019, Antalya
16. National Internal Medicine Congress, October 12-16, 2016, Antalya
17. Çapa Nephrology and Transplantation Days, March 2-5, 2017, Sapanca
18. Anatolian Rheumatology Days, May 1-5, 2019, Cyprus
19. Target Symposium in Rheumatology, March 7-10, 2018, Istanbul
20. Training Course for Rheumatology Residency Students and Specialists, January 9-12, 2020, Antalya
21. National Rheumatology Congress, September 26-30, 2018, Bodrum
22. Mediterranean Rheumatology Symposium, April 25-29, 2019, Antalya
23. Traditional Internal Medicine Days, March 12-15, 2020, Sapanca
24. Traditional Internal Medicine Days, March 15-18, 2018, Sapanca
25. Cerrahpaşa Behçet’s Disease Symposium, February 21-22, 2020, Istanbul
26. Psoriatic Arthritis Course, May 21-22, 2021, Online
27. EULAR 2021, online
28. American College of Rheumatology Congress 2021, Online
29. American College of Rheumatology Congress 2020, Online
30. Mediterranean Rheumatology Symposium, October 23-24, 2020, Antalya
31. Ankara Rheumatology Meeting, September 4-6, 2020, online
32. Anatolian Rheumatology Days, May 25-29, 2022, Cyprus
33. Ankara Rheumatology Meeting, September 9-11, 2022, Bolu
34. International Meetings of Familial Mediterrenean Fever and Other Autoinflammatory Diseases, 17-19 May 2021, online
35. EULAR 2020, online
36. National Rheumatology Congress, October 12-17, 2020, Online
37. Target 2021 Symposium in Rheumatology, October 27-30, 2021, Istanbul
38. COVID-19 Pandemic and Rheumatic Diseases Multidisciplinary Meeting, November 28, 2020, online.
39. Rara Diseases in Rheumatology, December 15-16, Online
40. Traditional Internal Medicine Days, March 24-27, 2022, Sapanca